Can a Two-Drug combo beat single painkiller after stomach surgery?

NCT ID NCT07768514

First seen Aug 17, 2026 ยท Last updated Aug 17, 2026

Summary

This trial tests whether a combination of acetaminophen and ibuprofen (Maxigesic) given through an IV can control pain better than acetaminophen alone after laparoscopic or robotic stomach cancer surgery. About 90 adults undergoing this surgery will be randomly assigned to one of the two treatments, and their pain levels will be tracked for 72 hours. The goal is to see if the combo reduces pain more effectively and safely, potentially lowering the need for stronger opioid painkillers.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
A fixed-dose combination of acetaminophen and ibuprofen, given intravenously as Maxigesic
What this could lead to
If effective, this could offer a better, opioid-sparing way to manage pain after gastric cancer surgery, potentially reducing opioid-related side effects.
What could go wrong
This is a small, phase 2 trial, so results may not apply broadly. The combination may not prove superior to acetaminophen alone, and there are risks like bleeding or kidney issues from ibuprofen.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Seoul National University Bundang Hospital

    Seongam, Gyeonggi-do, 13620, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.